Global $20 Billion Vitrification (IVF Clinics & Biobanks) Markets To 2027

DUBLIN, July 27, 2021 /PRNewswire/ -- The "Vitrification Market Size, Share & Trends Analysis Report by Specimen (Oocytes (Devices, Kits & Consumables), Embryo, Sperm), by End-use (IVF Clinics, Biobanks), by Region, and Segment Forecasts, 2021 - 2027"...
Author:
Publish date:

DUBLIN, July 27, 2021 /PRNewswire/ -- The "Vitrification Market Size, Share & Trends Analysis Report by Specimen (Oocytes (Devices, Kits & Consumables), Embryo, Sperm), by End-use (IVF Clinics, Biobanks), by Region, and Segment Forecasts, 2021 - 2027" report has been added to ResearchAndMarkets.com's offering.

The global vitrification market size is expected to reach USD 20.3 billion by 2027

The market is expected to expand at a CAGR of 17.7% from 2021 to 2027. Several experiments and investigations have been conducted to prove the efficiency of vitrification over slow freezing, leading to its increased clinical implementation. Currently, most IVF clinics are using this method to freeze the eggs/embryos and deliver a higher success rate to patients, thereby driving the market.Increasing infertility rates have significantly driven the fertility preservation space. Preserving biospecimens has become a common trend among consumers in order to avoid the subsequent consequences of delayed childbearing.

Furthermore, increasing awareness of reproductive health has driven the attention of people towards the freezing of biospecimens. This has created commercial opportunities for players such as Vitrolife and IVF Store that are engaged in offering vitrification solutions for fertility preservation.The increasing infertility rate is further propelling the demand for products offered in this market. On the other hand, ethical concerns about the preservation of eggs and sperms have hampered the market revenue to a considerable extent. The government and regulatory bodies are working towards addressing the concerns by introducing guidelines on various aspects of fertility preservation space. Vitrification Market Report Highlights

  • Currently, vitrification is primarily preferred for the egg-freezing cycle, due to its high success rate over conventional techniques
  • The relatively high upfront cost of embryo freezing, compared to egg freezing, has reduced penetration of this segment as compared to the oocytes segment
  • However, with the number of increasing IVF cycles, the oocytes segment is anticipated to be a lucrative option
  • On the other hand, although semen preservation has been performed before oocytes preservation, in the fast freezing market, these biospecimens account for a very low share in clinical implementation
  • However, a substantial number of researches are being carried out to support the clinical implementation of vitrification under this segment
  • Furthermore, the IVF clinics segment dominated the market in 2020 owing to the high usage of rapid cooling devices for oocytes preservation for future IVF procedures
  • The biobanks segment is expected to witness considerable growth over the forecast period owing to the increase in the number of individuals seeking fertility preservation services
  • Europe is recognized as the leader in Assisted Reproductive Technology (ART) space. This has positively favored the high revenue share of this region in the market in 2020
  • Following Europe, North America accounted for the significant revenue share in 2020 owing to the increasing investment in R&D for new vitrification solutions coupled with effective regulatory guidelines to support the fertility preservation arena
  • The Asian countries are expected to emerge as the lucrative source of revenue owing to the declining fertility rate in countries coupled with the subsequent increase in demand for vitrification products
  • The key companies are engaged in making strategic alliances with other operating players to expand the distribution and market reach of their products

Key Topics Covered:

Chapter 1 Research Methodology1.1 Information Procurement1.2 Information or Data Analysis1.3 Market Scope & Definitions1.4 Market Model1.4.1 Fertility Rate Study, By Country1.4.2 Market study, by Specimen & Product1.4.3 Market study, by end use Chapter 2 Executive Summary2.1 Market Summary, 2020 (Usd Million) Chapter 3 Market Variables, Trends, & Scope3.1 Market Dynamics3.1.1 Market driver analysis3.1.1.1 Increase in demand due to delayed childbearing/parenthood3.1.1.2 Social acceptance of fertility preservation techniques3.1.1.3 Rising awareness about reproductive health3.1.1.4 Increase in prevalence of infertility and infecundity3.1.2 Market Restraint Analysis3.1.2.1 Technical and ethical challenges of fertility preservation3.1.2.2 Low risk-benefit ratio3.1.3 Market Opportunity Analysis3.1.3.1 Advent of automated vitrification equipment3.2 Penetration and Growth Prospect Mapping for Specimen, 20203.3 Pricing Analysis3.3.1 Conclusion3.4 Vitrification Market: Company Market Share Analysis, by Region3.4.1 Company size (2020 Revenue (million))3.4.2 Geographic Presence3.4.3 Service/product portfolio3.4.4 Segment coverage3.4.5 Marketing strategies3.4.6 Conclusion3.5 Business Environment Tools3.5.1 Vitrification Market - SWOT Analysis, by Factor (Political & Legal, Economic, and Technological)3.5.2 Industry Analysis - Porter's Chapter 4 Specimen Business Analysis4.1 Vitrification Market: Specimen Movement Analysis4.2 Oocytes4.2.1 Global oocytes vitrification market, 2016 - 2027 (USD Million)4.2.2 Vitrification Devices4.2.3 Vitrification Kits & Consumables4.3 Embryo4.3.1 Global embryo vitrification market, 2016 - 2027 (USD Million)4.3.2 Vitrification Devices4.3.3 Vitrification Kits & Consumables4.4 Sperm Chapter 5 End-Use Business Analysis5.1 Vitrification Market: End-use Movement Analysis5.2 IVF Clinics5.3 Biobanks Chapter 6 Vitrification Market: Regional Business Analysis6.1 Vitrification Market: Regional Movement Analysis Chapter 7 Company Profiles

  • IVF Store
  • frozen cell
  • vitrolife
  • cook medical inc (Cook)
  • Minitube
  • IMV Technologies
  • coopersurgical fertility and genomic solutions
  • FUJIFILM IRVINE SCIENTIFIC
  • Biotech, Inc. (Cryolock)
  • Kitazato Corporation

For more information about this report visit https://www.researchandmarkets.com/r/5a1glb

Media Contact:

Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716

View original content: https://www.prnewswire.com/news-releases/global-20-billion-vitrification-ivf-clinics--biobanks-markets-to-2027-301342291.html

SOURCE Research and Markets